Copyright © 2004 by the European Society of Cardiology.
Review
Inflammation and restenosis after percutaneous coronary interventions
a Department of Cardiology, Athens Medical School, 9 Tepeleniou Str., 15452 Paleo Psychico Athens, Greece
b EMO Centro Cuore Columbus and San Raffaele Hospital, Milan, Italy
Received November 17, 2003;
revised May 19, 2004;
accepted June 3, 2004
* Corresponding author. Tel.: +30-210-671-8694; fax: +30-210-645-7230/+3010-210-6457230/7485039
cstefan{at}cc.uoa.gr
The role of inflammation in the development of restenosis after percutaneous coronary interventions has been investigated in several studies. There is an interaction of inflammatory activation and vascular wall response to injury leading to intimal hyperplasia. Percutaneous interventions trigger inflammatory reactions leading to the development of intimal hyperplasia. This reaction is even more prominent in atheromatic plaques in which inflammatory cells have already been activated. In the clinical setting there are several methods for the recognition of the inflammatory activation. In this article we review the data for the role of inflammatory process in restenosis and the significance of identifying the inflamed lesions prior to the intervention. Moreover, the therapeutic implications for the inhibition of inflammatory activation are mentioned.
Key Words: Inflammation • Restenosis • Angioplasty
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  H. A. Tran, S. D. Barnett, S. L. Hunt, A. Chon, and N. Ad The effect of previous coronary artery stenting on short- and intermediate-term outcome after surgical revascularization in patients with diabetes mellitus. J. Thorac. Cardiovasc. Surg., August 1, 2009; 138(2): 316 - 323. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. Niccoli, D. Schiavino, F. Belloni, G. Ferrante, G. La Torre, M. Conte, N. Cosentino, R. A. Montone, V. Sabato, F. Burzotta, et al. Pre-intervention eosinophil cationic protein serum levels predict clinical outcomes following implantation of drug-eluting stents Eur. Heart J., June 1, 2009; 30(11): 1340 - 1347. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Massoudy, M. Thielmann, N. Lehmann, A. Marr, G. Kleikamp, A. Maleszka, A. Zittermann, R. Korfer, M. Radu, A. Krian, et al. Impact of prior percutaneous coronary intervention on the outcome of coronary artery bypass surgery: A multicenter analysis J. Thorac. Cardiovasc. Surg., April 1, 2009; 137(4): 840 - 845. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C.-C. Wu, S.-C. Wen, C.-W. Yang, S.-Y. Pu, K.-C. Tsai, and J.-W. Chen Plasma ADMA Predicts Restenosis of Arteriovenous Fistula J. Am. Soc. Nephrol., January 1, 2009; 20(1): 213 - 222. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Jimenez-Valero, R. Moreno, A. Sanchez-Recalde, G. Galeote, L. Calvo, A. Viana, E. Lopez de Sa, and J. Lopez-Sendon Review: Avoiding restenosis: is there a role for glucocorticoids in the drug-eluting stent era? Therapeutic Advances in Cardiovascular Disease, June 1, 2008; 2(3): 137 - 146. [Abstract] [PDF]
|
|
|
|
 |
|
 M. Thielmann, R. Leyh, P. Massoudy, M. Neuhauser, I. Aleksic, M. Kamler, U. Herold, J. Piotrowski, and H. Jakob Prognostic Significance of Multiple Previous Percutaneous Coronary Interventions in Patients Undergoing Elective Coronary Artery Bypass Surgery Circulation, July 4, 2006; 114(1_suppl): I-441 - I-447. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 W. J. Gomes and E. Buffolo Coronary stenting and inflammation: implications for further surgical and medical treatment. Ann. Thorac. Surg., May 1, 2006; 81(5): 1918 - 1925. [Abstract] [Full Text] [PDF]
|
|